Answer
Stopping Efavirenz/Emtricitabine/Tenofovir disoproxil Glenmark in HIV/HBV co-infection may cause severe acute hepatitis exacerbations, requiring clinical and laboratory monitoring for at least four months; discontinuation is not recommended in advanced liver disease or cirrhosis because exacerbations may cause hepatic decompensation.
Sources for this answer
- Efavirenz/Emtricitabine/Tenofovir disoproxil Glenmark 600 mg/ 200 mg/245 mg film-coated tabletsGlenmark Pharmaceuticals Europe Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 5Document updated
Sources checked